{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:00:53Z","timestamp":1792450853364,"version":"4.5.0"},"reference-count":34,"publisher":"Informa Healthcare","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.1185\/03007995.2013.840568","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T12:44:56Z","timestamp":1378903496000},"page":"1719-1726","source":"Crossref","is-referenced-by-count":198,"title":["QT interval prolongation and the risk of torsades de pointes: essentials for clinicians"],"prefix":"10.1185","volume":"29","author":[{"given":"Katy E.","family":"Trinkley","sequence":"first","affiliation":[{"name":"University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences\rAurora, COUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert","family":"Lee Page","sequence":"additional","affiliation":[{"name":"University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences\rAurora, COUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang","family":"Lien","sequence":"additional","affiliation":[{"name":"University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences\rAurora, COUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yamanouye","sequence":"additional","affiliation":[{"name":"University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences\rAurora, COUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Purdue University\rWest Lafayette, INUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192704"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04193.x"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.11.1363"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.2165\/11598160-000000000-00000"},{"key":"CIT0005","first-page":"485","volume-title":"Drug-induced diseases. Prevention, detection and management","author":"Tisdale JE","year":"2010","edition":"2"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.01.040"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.84.3.1136"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2005.02.011"},{"key":"CIT0009","first-page":"353","volume":"7","author":"Bazett HC","year":"1920","journal-title":"Heart"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181c0dd5f"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.3.220"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00468-7"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810013391404"},{"key":"CIT0014","unstructured":"European Medicines Agency. The clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. Available at http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002879.pdf [Last accessed 18 February 2013]"},{"key":"CIT0015","first-page":"253","volume":"7","author":"Solomon R","year":"1987","journal-title":"Semin Nephrol"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000085057.63483.9b"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.056"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000014448.19052.4C"},{"key":"CIT0019","unstructured":"Food and Drug Administration. Drug development and drug interactions: Table of substrates, inhibitors and inducers. 2011. Available at: http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/DrugInteractionsLabeling\/ucm093664.htm#classInhibit [Last accessed 18 February 2013]"},{"key":"CIT0020","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. 2011. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm297391.htm [Last accessed 18 February 2013]"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f288"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1112"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00103"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-010-9288-2"},{"key":"CIT0025","unstructured":"Food and Drug Administration. FDA Drug Safety Communication: abnormal heart rhythms may be associated with use of Zofran (ondansetron). Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm271913.htm [Last accessed 18 February 2013]"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.037911"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2007.00912.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-007-9124-y"},{"key":"CIT0029","first-page":"30","volume":"77","author":"Russo V","year":"2006","journal-title":"Acta Biomed"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.01572.x"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7753(01)72036-2"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.50146.x"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003833"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000152"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2013.840568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:45:06Z","timestamp":1599410706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2013.840568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["10.1185\/03007995.2013.840568"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2013.840568","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]}}}